The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A validation study of stratification by the 55-gene classifier for assessing recurrence risk in stage II colon cancer: The 55 STAR study (UMIN23879).
 
Shigeki Yamaguchi
Speakers' Bureau - Chugai Pharma; Lilly; Merck Serono; Taiho Pharmaceutical
 
Kazuo Hase
No Relationships to Disclose
 
Eiji Shinto
No Relationships to Disclose
 
Eiji Oki
Speakers' Bureau - Bayer Yakuhin; Chugai Pharma; Lilly Japan; Merck Serono; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Mototsugu Shimokawa
Consulting or Advisory Role - Sysmex
 
Megumi Ishiguro
Honoraria - Merck Serono; Taiho Pharmaceutical; Yakult Pharmaceutical
Consulting or Advisory Role - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical; Yakult Pharmaceutical
 
Masaru Morita
No Relationships to Disclose
 
Tetsuya Kusumoto
No Relationships to Disclose
 
Naohiro Tomita
No Relationships to Disclose
 
Yojiro Hashiguchi
Honoraria - Chugai Pharma; Kaken Pharmaceutical; Merck Serono; Taiho Pharmaceutical; Takeda
 
Masafumi Tanaka
No Relationships to Disclose
 
Shinobu Ohnuma
No Relationships to Disclose
 
Sachiyo Tada
No Relationships to Disclose
 
Tomoko Matsushima
No Relationships to Disclose